Acupuncture for Unexplained Subfertiliy (AURIS)

December 17, 2015 updated by: Xiaoke Wu, Heilongjiang University of Chinese Medicine

A Randomized Controlled Trial of Acupuncture Versus Expectant Management in Women With Unexplained Infertility

Infertility affects one in six couples. In a quarter of them, routine tests of semen quality, ovulation or tubal patency fail to reveal any abnormalities and the cause of infertility is unexplained. Acupuncture is being increasingly used by couples with all types of infertility and initial trials have suggested that it could be potentially beneficial in some cases. A number of systematic reviews of acupuncture in IVF have shown conflicting results, but there is no evidence to inform best practice in unexplained infertility. In addition, as an intervention, acupuncture is not cost neutral as it involves multiple visits for treatment sessions delivered by a skilled practitioner. Thus, while acupuncture could have the potential to increase live birth rates in women with unexplained infertility, the clinical and cost effectiveness of acupuncture needs to be confirmed in the context of a large randomized controlled trial.

Study Overview

Status

Unknown

Study Type

Interventional

Enrollment (Anticipated)

1423

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hangzhou, China, 310000
        • Hangzhou Chinese Medicine Hospital
    • Guangdong
      • Guangzhou, Guangdong, China
        • Guangzhou Medical School First Affiliated Hospital
    • Heilongjiang
      • Daqing, Heilongjiang, China, 163000
        • The Daqing Oilfield General Hospital
      • Daqing, Heilongjiang, China
        • Daqing Oilfield General hospital
      • Daqing, Heilongjiang, China
        • Daqing Longnan hospital
      • Harbin, Heilongjiang, China, 150040
        • Department of Obstetrics and Gynecology,First Affliated Hospital,Heilongjiang University of Chinese Medicine .
      • Harbin, Heilongjiang, China, 150040
        • Obstetrics and Gynecology,Heilongjiang University of Chinese Medicine
    • Hunan
      • Changsha, Hunan, China
        • First Affiliated Hospital of Hunan University of Chinese
    • Jiangsu
      • Xuzhou, Jiangsu, China
        • Maternal and Child Health Hospital of Xuzhou
    • Jiangxi
      • Nanchang, Jiangxi, China, 330000
        • Jiangxi University of Chinese Medicine Affiliated Hospital
      • Nanchang, Jiangxi, China
        • First Hospital, Jiangxi college of Chinese Medicine
    • Shanxi
      • Shangxi, Shanxi, China, 030012
        • Shanxi Chinese Medicine Hospital
      • Taiyuan, Shanxi, China
        • Shanxi Hospital of Chinese Medicine
    • Tianjin
      • Tianjin, Tianjin, China, 300451
        • Tianjin Tanggu Maternity and Child Care Center
      • Tianjin, Tianjin, China
        • First Affiliated Hospital of Tianjin University of Chinese Medicine
    • Zhejiang
      • Wenzhou, Zhejiang, China, 325000
        • Wenzhou Chinese Medicine Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion criteria

  1. Women aged 18-40 years
  2. Bilateral patent tubes demonstrated by hysterosalpingogram, hysterosalpingo-contrast sonography or laparoscopy
  3. Regular menses 21 to 35 days Normal semen parameters :Total motile sperm count ≥10 million. (World Health Organization criteria, 2010)

Exclusion criteria

  1. Unwillingness to accept either of the two interventions
  2. Contra-indications to acupuncture: pacemaker use or bleeding disorder
  3. Received acupuncture before 2 months for other diseases which are not related to unexplained infertility.
  4. Previously received acupuncture for unexplained infertility
  5. Use of hormonal or other medication (including Chinese Herbal prescriptions) which may affect the outcome in the past 2 months.
  6. Patients who anticipate taking longer than a one month break from treatment during the trial (i.e. 4 months from randomization).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Acupuncture plus expectant management
semi-fixed protocol will be used including four local core points; conception vessel (CV) 3, CV 6, and stomach (ST) 29 bilaterally and four in the leg/feet; spleen (SP) 6, and SP 9 bilaterally. The core points CV 3, CV 6, ST 29, SP 6, and SP 9 are thereafter connected to electrical stimulator (Hwoto, China) and stimulated with low-frequency, 2Hz, 0.5 ms
one initial counselling session, an information leaflet on timed intercourse, access to a telephone helpline for queries and ad hoc support on demand from the fertility clinic over a period of 4 months post randomization.
Active Comparator: expectant management
one initial counselling session, an information leaflet on timed intercourse, access to a telephone helpline for queries and ad hoc support on demand from the fertility clinic over a period of 4 months post randomization.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
live birth rate
Time Frame: Up to 4 months
Up to 4 months

Secondary Outcome Measures

Outcome Measure
Time Frame
pregnancy rate
Time Frame: Up to 14 months
Up to 14 months
Miscarriage rate
Time Frame: Up to 14 months
Up to 14 months
Other pregnancy complications such as early pregnancy loss, gestational diabetes mellitus, pregnancy-induced hypertension and birth of small-for-gestational-age (SGA) babies.
Time Frame: Up to 14 months
Up to 14 months
quality of life
Time Frame: Up to 14 months
Up to 14 months
Side effect
Time Frame: Up to 14 months
Up to 14 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Xiaoke Wu, MD.PhD., The First Affliated Hospital,Heilongjiang University of Chinese Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2015

Primary Completion (Anticipated)

January 1, 2018

Study Registration Dates

First Submitted

November 24, 2015

First Submitted That Met QC Criteria

December 3, 2015

First Posted (Estimate)

December 8, 2015

Study Record Updates

Last Update Posted (Estimate)

December 21, 2015

Last Update Submitted That Met QC Criteria

December 17, 2015

Last Verified

December 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AURIS2015

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Unexplained Infertility

Clinical Trials on Acupuncture

3
Subscribe